Overview

Intravenous Labetalol Versus Hydralazine in Preeclampsia

Status:
RECRUITING
Trial end date:
2024-12-20
Target enrollment:
Participant gender:
Summary
We study the effect of intravenous labetalol versus hydralazine in sever preeclampsia patients on cerebral blood flow and neurological outcome
Phase:
PHASE1
Details
Lead Sponsor:
Tanta University
Treatments:
Hydralazine
Labetalol